New Product: Nimenrix (meningococcal Group A, C, W135 and Y conjugate vaccine) powder and solvent for solution -

New Product: Nimenrix (meningococcal Group A, C, W135 and Y conjugate vaccine) powder and solvent for solution
Information type: Drug prescribing
Source: Glenmark Pharmaceuticals Europe Ltd
Specialities: Vaccination
Summary
Nimenrix (meningococcal Group A, C, W135 and Y conjugate vaccine) is licensed for active immunisation of individuals from the age of 12 months and above against invasive meningococcal diseases caused by Neisseria meningitidis group A, C, W-135 and Y
UKMi comment
This is a new formulation of the vaccine. It is also available as a pre-filled syringe.
Related links: Pre-filled syringe SPC: